Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
So low cost! It's worth geting penis vibrator in our Sex Toys Store.
Popular Articles

New Breast Implant Designed As Alternative To Silicone Gel
At a time when breast augmentation tops the list for U.S. cosmetic surgical procedures, women are still left choosing between either the safety of saline or the natural result of silicone gel. Plastic surgeons are now looking to offer the best features of both in the revolutionary new technology of the IDEAL IMPLANT® Saline-filled Breast Implant. A clinical trial is launching this month in select markets nationwide, giving some women the opportunity to be among the first to have this new implant.
pharmacy online Dentisti fiume
Applied Infectious Disease Epidemiology Conference, Stockholm, Stockholm, October 26-28, 2009
"Epidemiology is always important and topical, though sometimes unsung," says Professor Johan Giesecke, Chief Scientist at ECDC, the European Centre for Disease Prevention and Control, "but the third applied Infectious Disease Epidemiology Conference in Stockholm in October this year will be an opportunity to put Epidemiology and infectious disease prevention and control into the spotlight; delegates will have the opportunity to discuss and share information on current and emerging infectious diseases, including influenza A (H1N1)v. The call for abstracts closes on July 3rd so there is no time to lose."
News of the day
Tuberculosis Vaccine Too Risky For HIV-Infected Infants
HIV-infected infants risk contracting a deadly form of tuberculosis from the bacille Calmette-Guerin (BCG) vaccine, instead of receiving protection against the disease, according to research published today in the international public health journal, the Bulletin of the World Health Organization.
Health Insurance

QRESEARCH Team Welcome New Validation Of QRISK formula for identifying those most at risk of developing heart disease

The University of Nottingham and leading healthcare systems supplier EMIS welcomed a new, independent validation of the QRISK formula for identifying those most at risk of developing heart disease. The two organisations worked together, through the not-for-profit partnership QResearch, to develop the ground-breaking formula which has been strongly endorsed in new research published in the BMJ . Researchers from the University of Oxford have recommended its widespread use across the UK in place of the more commonly-used Framingham equation. Commenting on the new research, Professor Julia Hippisley-Cox of The University of Nottingham"s Division of Primary Care, said: "We are delighted to receive another strong endorsement of the value of QRISK in assessing the risk of heart disease in the UK population. "We believe this formula has the potential to save many thousands of lives, by helping clinicians to more accurately predict those at risk of developing cardiovascular disease - the nation"s biggest killer. "It will arm doctors with all the information they need to decide how best to target patients with preventative measures such as lifestyle advice and cholesterol-lowering treatments." The 56 per cent of GPs in the UK who use EMIS clinical records systems can already access the QRISK2 formula - an improved version of the original algorithm - which has been embedded in their systems. EMIS Managing Director Sean Riddell said: "We are pleased to confirm that all EMIS GPs can now benefit from QRISK2, and we would like to thank all those GPs who contributed anonymous patient data to support the development of this vital clinical tool." Other clinical systems providers can access the new equation through a software development kit that has been designed to ensure the safe and accurate use of the formula. The QRISK algorithm is also being made available for further academic research. EMIS


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009